A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.

Transcutaneous immunization (TCI) is a promising needle-free, easy-to-use, and low-invasive vaccination method. The hydrogel patch-based TCI system induced immune responses against soluble antigens (Ags) like toxoids, but could not induce immune responses against particulate Ags. Here, as an effective TCI system against every form of Ag, we developed a dissolving microneedle array of three lengths (200, 300, or 800 μm) made of hyaluronate as a novel TCI device. Unlike conventional microneedles, the microneedles of our dissolving microneedle arrays dissolved in the skin after insertion. Each dissolving microneedle array effectively delivered both soluble and particulate Ags under the stratum corneum. TCI using these dissolving microneedle arrays induced effective immune responses in rats regardless of the Ag form that were comparable to conventional vaccination using subcutaneous immunization. In addition, application of these dissolving microneedle arrays caused only slight skin irritation. These findings suggest that our TCI system can simply, safely, and effectively improve protective immune responses for every vaccine Ag.

[1]  アーネスト オレッティー，ジョン,et al.  The drug delivery device , 1994 .

[2]  G. Glenn,et al.  Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch , 2007, Expert review of vaccines.

[3]  Y. Rojanasakul,et al.  Vaccine delivery--current trends and future. , 2006, Current drug delivery.

[4]  A. Larregina,et al.  Professional antigen-presenting cells of the skin , 2006, Immunologic research.

[5]  T. Kepler,et al.  Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants , 2010, Proceedings of the National Academy of Sciences.

[6]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[7]  S. Bhatia.  The Spleen , 1929, The Indian medical gazette.

[8]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[9]  J. Maizel,et al.  The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. , 1974, Virology.

[10]  S. Nakagawa,et al.  A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection , 2008, Journal of Controlled Release.

[11]  Henry,et al.  Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.

[12]  F. Ginhoux,et al.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells , 2008, Nature Reviews Immunology.

[13]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[14]  M. Kay,et al.  Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. , 1998, Human gene therapy.

[15]  B. W. Barry,et al.  Breaching the skin's barrier to drugs , 2004, Nature Biotechnology.

[16]  E. Devilard,et al.  The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells , 2007, The Journal of experimental medicine.

[17]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[18]  K. Hogquist,et al.  Identification of a novel population of Langerin+ dendritic cells , 2007, The Journal of experimental medicine.

[19]  杉田 和成.  Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin , 2008 .

[20]  J. Jensen,et al.  The skin's barrier. , 2009, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[21]  N. Romani,et al.  Langerhans cells and more: langerin‐expressing dendritic cell subsets in the skin , 2010, Immunological reviews.

[22]  Y. Yoshioka,et al.  Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[23]  H. Schild,et al.  Initiation of adaptive immune responses by transcutaneous immunization. , 2007, Immunology letters.

[24]  F. Ginhoux,et al.  Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state , 2007, The Journal of experimental medicine.

[25]  John H. Draize,et al.  METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .

[26]  E. H. Wilson.  Origin , 1927, Bulletin of popular information - Arnold Arboretum, Harvard University..

[27]  Gideon Kersten,et al.  Needle-free vaccine delivery , 2007, Expert opinion on drug delivery.

[28]  Joshua D. Shofner,et al.  Langerhans cells: mediators of immunity and tolerance. , 2006, The international journal of biochemistry & cell biology.

[29]  S. Nakagawa,et al.  Characterization of transcutaneous protein delivery by a hydrogel patch in animal, human, and tissue-engineered skin models. , 2011, Biological & pharmaceutical bulletin.

[30]  C. Hirunpetcharat,et al.  The spleen, IgG antibody subsets and immunity to Plasmodium berghei in rats , 1997, Immunology and cell biology.